Oxidative stress and birth defects in infants of women with pregestational diabetes

MEDICC Review

Volumn 15, Issue 1, 2013, Pages 37-40

  Clapés, Sonia ^a   Fernández, Tammy ^a   Suárez, Gipsis ^a  

^a Medical University of Havana   (Cuba)

Author keywords

Birth defects; Congenital abnormalities; Cuba; Diabetes mellitus; Gene expression; Glucose metabolism disorders; Hyperglycemia; Oxidative stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALDEHYDE REDUCTASE; ALPHA TOCOPHEROL; GLUCOSAMINE; GLUTATHIONE REDUCTASE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

BIRTH DEFECT; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CONCEPTION; EMBRYO DEVELOPMENT; EMBRYOPATHY; FEMALE; FETUS DEVELOPMENT; GENE EXPRESSION; GENETIC COUNSELING; GENOTOXICITY; GLOMERULUS; GLYCOSYLATION; HUMAN; HYPERGLYCEMIA; INFANT; METABOLIC REGULATION; MORBIDITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PERIPHERAL NERVE; PREGNANCY DIABETES MELLITUS; PROTEIN EXPRESSION; RETINA; REVIEW;

EID: 84873368139     PISSN: 15557960     EISSN: 15273172     Source Type: Journal    
DOI: 10.1590/S1555-79602013000100009     Document Type: Review

References (20)

1. Ashcroft FM, Rorsman P. Diabetes mellitus and the β Cell: the last ten years. Cell. 2012 Mar 16; 148(6): 1160-71.
2. Inzucchi SE. Clinical practice. Diagnosis of diabetes. N Engl J Med. 2012 Aug 9; 367(6): 542-50.
3. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010 Oct 29; 107(9): 1058-70.
4. Diabetes Control and Complications Trial Research Group. Pregnancy outcomes in the Diabetes Control and Complications Trial. Am J Obstet Gynecol. 1996 Apr; 174(4): 1343-53.
5. Anuario Estadístico 2011 [Internet]. Havana: Ministry of Public Health (CU); 2012 [cited 2012 Jun 23]. Available from: http://files.sld.cu/dne/ files/2012/04/anuario-2011-e.pdf. Spanish.
6. Freinkel N. Banting Lecture 1980. Of pregnancy and progeny. Diabetes. 1980 Dec; 29(12): 1023-35.
7. Fetita LS, Sobngwi E, Serradas P, Calvo F, Gautier JF. Consequences of fetal exposure to maternal diabetes in offspring. J Clin Endocrinol Metab. 2006 Oct; 91(10): 3718-24.
8. Loeken MR. Advances in understanding the molecular causes of diabetes-induced birth defects. Soc Gynecol Investig. 2006 Jan; 13(1): 2-10.
9. Ericksson UJ, Cederberg J, Wentzel P. Congenital malformations in offspring of diabetic mothers. Animal and human studies. Rev Endocr Metab Disord. 2003 Mar; 4(1): 79-93.
10. González E. Diabetes experimental: etiología de malformaciones congénitas en descendientes de ratas diabéticas. Rev Cubana Endocrinol. 2002; 13(1): 53-63. Spanish.
11. Farrell T, Neale L, Cundy T. Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diabet Med. 2002 Apr; 19(4): 322-6.
12. Chen CP. Congenital malformations associated with maternal diabetes. Taiwanese J Obstet Gynecol. 2005 Mar 1; 44(1): 1-7.
13. Wu Y, Viana M, Thirumangalathu S, Loeken MR. AMP-activated protein kinase mediates effects of oxidative stress on embryo gene expression in a mouse model of diabetic embryopathy. Diabetologia. 2012 Jan; 55(1): 245-54.
14. Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest. 2006 Jul; 116(7): 1776-83.
15. Gorrita Y, Núñez N, Fernández T, Clapés S. Malformaciones congénitas en la descendencia de ratas diabéticas [Congenital anomalies in diabetic rats descendants]. Rev Haban Cienc Med. Spanish. Forthcoming.
16. Marcheco B. El programa nacional de diagnóstico, manejo y prevención de enfermedades genéticas y defectos congénitos de Cuba: 1981-2009. Rev Cubana Genética Comun. 2009; 3 (2-3): 167-84. Spanish.
17. Guillén M, Valdés L, Lang J. Programa Nacional Cubano de Atención Integral a la Gestante con Diabetes Mellitus. Conferencia. Libro resumen COPAEN 2012. XIII Congreso Latinoamericano de Endocrinología; 2012 May 11; Havana, Cuba. p 11. Spanish.
18. Álvarez AG, García A, Gorbea MH. Pautas conceptuales y metodológicas para explicar los determinantes de los niveles de salud en Cuba. Rev Cubana Salud Pública. 2007; 33(2). Spanish.
19. McElvy SS, Miodovnik M, Rosenn B, Khoury JC, Siddigi T, Dignan PS, et al. A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern Fetal Med. 2000 Jan-Feb; 9(1): 14-20.
20. Vigneri R, Squatrito S, Frittitta L. Selective insulin receptor modulators (SIRM): a new class of antidiabetes drugs? Diabetes. 2012 May; 61(5): 984-5.